文献速递关节外科

美国关节置换登记数据与国际髋膝关节置换生存率的一致性比较分析

Is American Joint Replacement Registry Data Consistent With International Survivorship in Hip and Knee Arthroplasty? A Comparative Analysis.
PubMed 文献 · J Arthroplasty · 2024-02-27

美国关节置换登记(AJRR)与骨科数据评估小组(ODEP)合作,选取3种膝关节和3种髋关节假体,比较AJRR与英国国家关节登记(NJR)的Kaplan-Meier生存率。结果示全年龄段及≥65岁队列一致性最高,髋关节最终随访平均差异0.18%。

要点

  • 全膝关节置换中,PS和CR假体在3个年龄队列的生存率均达到统计学一致。
  • 单间室膝关节置换仅在Medicare队列达到统计学一致。
  • 全髋关节置换最终随访(8年)生存率平均差异为0.18%。

核心结论

  • AJRR与NJR在髋膝关节置换的性能趋势和生存率上相似,全年龄段和≥65岁队列一致性最高。
  • 作者认为这一集中比较的结果令人鼓舞,表明AJRR患者结局的可靠性相比全球最大关节置换登记具有良好前景,对全球患者安全改进有重要意义。

研究设计与样本

  • AJRR与ODEP合作,选取3种性能已知变异的膝关节假体和3种髋关节假体。
  • 植入物制造商基于NJR数据独立生成Kaplan-Meier生存率并提交ODEP比较,AJRR镜像该方法。
  • 两来源结果按全年龄段、<65岁和≥65岁三个队列分层。

主要发现

  • 膝关节:AJRR有42,671例,NJR有60,439例初次膝关节置换病例;髋关节:AJRR有70,169例,NJR有422,657例初次全髋关节置换病例。
  • 全膝关节置换中,AJRR与NJR性能一致,高性能和低性能假体趋势相似;PS和CR假体在所有3个队列生存率均达到统计学一致。
  • 单间室膝关节置换比较在Medicare队列达到统计学一致;全年龄段和<65岁队列趋势相似,分别至7年和6年达到统计学一致。
  • 全髋关节置换中,AJRR与NJR性能一致,高性能和低性能假体趋势相似;最终随访(8年)生存率平均差异0.18%。
  • 一种股骨假体未达到统计学一致,但生存率差异仅0.61%;其余髋臼和股骨假体在全年龄段及≥65岁队列分别至7年和8年达到统计学一致。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In collaboration with the Orthopedic Data Evaluation Panel (ODEP), the American Joint Replacement Registry (AJRR) investigated the consistency of hip and knee arthroplasty survivorship results compared to the UK National Joint Registry (NJR). METHODS: A total of three primary knee devices and three primary hip devices were selected by AJRR and ODEP with known variation in performance. Implant manufacturers independently produced Kaplan Meier survivorship based on NJR data and submitted to ODEP for comparison. The AJRR mirrored the methodology, and results from both sources were stratified into three cohorts (all-age, < 65, and ≥ 65 years). RESULTS: There were 42,671 AJRR and 60,439 NJR primary knee cases and 70,169 AJRR and 422,657 NJR primary total hip arthroplasty cases. For TKA, performance between the AJRR and NJR were consistent, showing similar trends for comparatively high and low performing devices. Both PS and CR devices showed statistical agreement in survivorship for all 3 cohorts. Unicompartmental comparison also showed statistical agreement for the Medicare cohort. The all-age and < 65-year-old cohorts showed similar trends and reached statistical agreement through 7 and 6 years. For total hip arthroplasty, performance between the AJRR and NJR were consistent, showing similar trends for comparatively high and low performing devices; 0.18% average difference in survivorship at final follow-up (8 years). One femoral device did not reach statistical agreement but showed only 0.61% difference in survivorship. The remaining acetabular and femoral devices reached statistical agreement in all-ages and through 7 and 8 years in the ≥ 65-year-old cohort. CONCLUSIONS: AJRR and NJR performance trends and survivorship were similar across hip and knee arthroplasty with greatest consistency in the all-age and ≥ 65 cohorts. This focused comparison of survivorship showed encouraging results for reliability of patient outcomes in AJRR compared to the world's largest joint arthroplasty registry which has strong implications for global improvement in patient safety.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Springer BD, Mullen KP, Donnelly PC, et al. Is American Joint Replacement Registry Data Consistent With International Survivorship in Hip and Knee Arthroplasty? A Comparative Analysis. J Arthroplasty. 2024. PMID: 38417557. doi:10.1016/j.arth.2024.02.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。